IS6915A - Lyfjablanda - Google Patents

Lyfjablanda

Info

Publication number: IS6915A
Authority: IS; Iceland
Prior art keywords: composition
Prior art date: 2001-02-27

Application number

IS6915A

Other languages

English (en)

Inventor

Bateman Nicola

Cahill Julie

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-27

Filing date

2003-08-15

Publication date

2003-08-15

2001-02-27 Priority claimed from GB0104749A external-priority patent/GB2372444A/en

2001-07-19 Priority claimed from SE0102572A external-priority patent/SE0102572D0/xx

2003-08-15 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2003-08-15 Publication of IS6915A publication Critical patent/IS6915A/is

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Inorganic Chemistry (AREA)
Engineering & Computer Science (AREA)
Physiology (AREA)
Nutrition Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IS6915A 2001-02-27 2003-08-15 Lyfjablanda IS6915A (is)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB0104749A GB2372444A (en)	2001-02-27	2001-02-27	A pharmaceutical formulation comprising bicalutamide and a hydroxypropylmethylcellulose polymer
SE0102572A SE0102572D0 (sv)	2001-07-19	2001-07-19	Pharmaceutical formulation
PCT/GB2002/000766 WO2002067893A2 (en)	2001-02-27	2002-02-22	Pharmaceutical formulation comprising bicalutamide

Publications (1)

Publication Number	Publication Date
IS6915A true IS6915A (is)	2003-08-15

Family

ID=26245766

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6915A IS6915A (is)	2001-02-27	2003-08-15	Lyfjablanda

Country Status (22)

Country	Link
US (1)	US20040067257A1 (is)
EP (1)	EP1368001B1 (is)
JP (2)	JP3548566B2 (is)
KR (1)	KR20030077042A (is)
CN (1)	CN1503662A (is)
AR (1)	AR032912A1 (is)
AT (1)	ATE307571T1 (is)
CA (1)	CA2439366A1 (is)
CZ (1)	CZ20032225A3 (is)
DE (1)	DE60206889T2 (is)
EE (1)	EE200300416A (is)
HU (1)	HUP0302847A3 (is)
IL (1)	IL157389A0 (is)
IS (1)	IS6915A (is)
MX (1)	MXPA03007641A (is)
NO (1)	NO20033785L (is)
NZ (1)	NZ527532A (is)
PL (1)	PL365746A1 (is)
RU (1)	RU2003128971A (is)
SK (1)	SK10722003A3 (is)
UY (1)	UY27186A1 (is)
WO (1)	WO2002067893A2 (is)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE0103424D0 (sv) *	2001-10-15	2001-10-15	Astrazeneca Ab	Pharmaceutical formulation
SE0103838D0 (sv) *	2001-11-16	2001-11-16	Astrazeneca Ab	Pharmaceutical formulation & product
TWI355276B (en) *	2003-01-14	2012-01-01	Akira Tsuji	Gastrointestinal absorption enhancer mediated by p
US20050008691A1 (en) *	2003-05-14	2005-01-13	Arturo Siles Ortega	Bicalutamide compositions
US20080138437A1 (en) *	2004-02-09	2008-06-12	Shuji Sakuma	Antitumor Agent
KR100539706B1 (ko) *	2005-01-25	2005-12-28	지엘팜텍 주식회사	타크로리무스 및 장용성 고분자를 함유하는 고체분산체
US20080161404A1 (en) *	2005-02-23	2008-07-03	Astrazeneca Ab	Bicalutamide for Delivering Increasing Steady State Plasma Levels
US8293274B2 (en) *	2005-04-06	2012-10-23	Kabushiki Kaisha Sangi	Intestinal absorptive anti-tumor agent
US7785629B2 (en) *	2005-06-21	2010-08-31	Helm Ag	Bicalutamide-adsorbates, process for preparing same, and pharmaceutical compositions thereof
JP5052051B2 (ja) *	2006-06-16	2012-10-17	トーアエイヨー株式会社	腸溶性顆粒剤及びその製造方法
US20080045600A1 (en) *	2006-08-17	2008-02-21	Gawande Rahul S	Bicalutamide compositions
WO2008063888A2 (en)	2006-11-22	2008-05-29	Plexxikon, Inc.	Compounds modulating c-fms and/or c-kit activity and uses therefor
AU2008276063B2 (en)	2007-07-17	2013-11-28	Plexxikon Inc.	Compounds and methods for kinase modulation, and indications therefor
WO2009038112A1 (ja)	2007-09-21	2009-03-26	Shionogi & Co., Ltd.	Ｎｐｙｙ５受容体拮抗剤を含有する固形製剤
JP5204452B2 (ja) *	2007-10-02	2013-06-05	日医工株式会社	ビカルタミド含有製剤
EP2219624A2 (en) *	2007-11-08	2010-08-25	Glaxo Group Limited	Pharmaceutical formulations
BRPI1008709B8 (pt) *	2009-04-03	2021-05-25	Hoffmann La Roche	dispersão sólida, formulação, composição e comprimido compreendendo {3-[5-(4-cloro-fenil)-1h-pirrol[2,3-b]piridina-3-carbonil]-2,4-diflúor-fenil}-amida do ácido propano-1-sulfônico
CN101987086B (zh) *	2009-08-03	2012-07-18	北京化工大学	一种超细比卡鲁胺口服片剂及其制备方法
US8329724B2 (en)	2009-08-03	2012-12-11	Hoffmann-La Roche Inc.	Process for the manufacture of pharmaceutically active compounds
US20110112127A1 (en)	2009-11-06	2011-05-12	Plexxikon, Inc.	Compounds and methods for kinase modulation, and indications therefor
CN102892411B (zh)	2009-12-18	2015-01-21	恩多提斯药业公司	含有合成的低聚糖的药物口服剂型
CN102525876B (zh) *	2010-12-15	2014-03-12	西安力邦医药科技有限责任公司	阿司匹林固体分散体、其制备方法、药物组合物和用途
CN102552103B (zh) *	2010-12-20	2013-11-20	西安力邦医药科技有限责任公司	拉米夫定固体分散体、其制备方法、药物组合物和用途
MY162950A (en)	2011-02-07	2017-07-31	Plexxikon Inc	Compounds and methods for kinase modulation, and indications therefor
AR085279A1 (es)	2011-02-21	2013-09-18	Plexxikon Inc	Formas solidas de {3-[5-(4-cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico
US9150570B2 (en)	2012-05-31	2015-10-06	Plexxikon Inc.	Synthesis of heterocyclic compounds
HUE057701T2 (hu)	2012-09-11	2022-05-28	Medivation Prostate Therapeutics Llc	Enzalutamid kiszerelési formái
SG11201700849XA (en) *	2014-08-07	2017-03-30	Pharmacyclics Llc	Novel formulations of a bruton's tyrosine kinase inhibitor
BR112017011788A2 (pt)	2014-12-05	2017-12-26	Aragon Pharmaceuticals Inc	composições anticâncer
SI3226843T1 (sl)	2014-12-05	2021-11-30	Aragon Pharmaceuticals, Inc.	Protirakavi sestavki
AU2017376544C1 (en) *	2016-12-15	2021-06-24	Hua Medicine (Shanghai) Ltd.	Oral preparation of glucokinase activator and preparation method therefor
MX2021012356A (es)	2019-04-11	2021-11-04	Scherer Technologies Llc R P	Formulación para suministro oral de proteínas, péptidos y moléculas pequeñas con poca permeabilidad.
GB2584341B (en) *	2019-05-31	2023-03-01	Gw Res Ltd	Cannabinoid formulations
US11344526B2 (en)	2020-03-20	2022-05-31	The Regents Of The University Of California	Implantable drug delivery devices for localized drug delivery
US11173291B2 (en) *	2020-03-20	2021-11-16	The Regents Of The University Of California	Implantable drug delivery devices for localized drug delivery

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0100172B1 (en) *	1982-07-23	1987-08-12	Imperial Chemical Industries Plc	Amide derivatives
JP2527107B2 (ja) *	1991-04-16	1996-08-21	日本新薬株式会社	固体分散体の製造方法
EP0748220A4 (en) *	1994-01-21	1997-09-10	Sepracor Inc	METHOD AND COMPOSITIONS FOR TREATING ANDROGEN-DEPENDENT DISEASES USING OPTICALLY PURE R - (-) CASODEX
US20030059471A1 (en) *	1997-12-15	2003-03-27	Compton Bruce Jon	Oral delivery formulation
MXPA03008999A (es) *	2001-04-02	2004-02-12	Astrazeneca Ab	Composicion farmaceutica solida que comprende 4-ciano -trifluor-3 -(4-fluorfenilsulfonil) -2-hidroxi-2 -metilpropino -m-toluidida y pvp.
SE0103424D0 (sv) *	2001-10-15	2001-10-15	Astrazeneca Ab	Pharmaceutical formulation
SE0103839D0 (sv) *	2001-11-16	2001-11-16	Astrazeneca Ab	Pharmaceutical formulation & product

2002
- 2002-02-22 EP EP02712105A patent/EP1368001B1/en not_active Expired - Lifetime
- 2002-02-22 SK SK1072-2003A patent/SK10722003A3/sk unknown
- 2002-02-22 AT AT02712105T patent/ATE307571T1/de not_active IP Right Cessation
- 2002-02-22 PL PL02365746A patent/PL365746A1/xx not_active Application Discontinuation
- 2002-02-22 CZ CZ20032225A patent/CZ20032225A3/cs unknown
- 2002-02-22 HU HU0302847A patent/HUP0302847A3/hu unknown
- 2002-02-22 DE DE60206889T patent/DE60206889T2/de not_active Expired - Fee Related
- 2002-02-22 NZ NZ527532A patent/NZ527532A/xx unknown
- 2002-02-22 KR KR10-2003-7011178A patent/KR20030077042A/ko not_active Withdrawn
- 2002-02-22 CN CNA028087356A patent/CN1503662A/zh active Pending
- 2002-02-22 RU RU2003128971/15A patent/RU2003128971A/ru not_active Application Discontinuation
- 2002-02-22 CA CA002439366A patent/CA2439366A1/en not_active Abandoned
- 2002-02-22 IL IL15738902A patent/IL157389A0/xx unknown
- 2002-02-22 MX MXPA03007641A patent/MXPA03007641A/es unknown
- 2002-02-22 US US10/468,276 patent/US20040067257A1/en not_active Abandoned
- 2002-02-22 EE EEP200300416A patent/EE200300416A/xx unknown
- 2002-02-22 JP JP2002567261A patent/JP3548566B2/ja not_active Expired - Fee Related
- 2002-02-22 WO PCT/GB2002/000766 patent/WO2002067893A2/en not_active Ceased
- 2002-02-26 UY UY27186A patent/UY27186A1/es not_active Application Discontinuation
- 2002-02-27 AR ARP020100712A patent/AR032912A1/es not_active Application Discontinuation
2003
- 2003-08-15 IS IS6915A patent/IS6915A/is unknown
- 2003-08-26 NO NO20033785A patent/NO20033785L/no not_active Application Discontinuation
2004
- 2004-02-18 JP JP2004041583A patent/JP2004143185A/ja active Pending

Also Published As

Publication number	Publication date
SK10722003A3 (sk)	2004-02-03
JP2004521918A (ja)	2004-07-22
EE200300416A (et)	2003-12-15
UY27186A1 (es)	2002-09-30
CA2439366A1 (en)	2002-09-06
MXPA03007641A (es)	2003-12-04
NO20033785L (no)	2003-10-24
DE60206889D1 (de)	2005-12-01
EP1368001A2 (en)	2003-12-10
HUP0302847A3 (en)	2005-05-30
IL157389A0 (en)	2004-05-12
NO20033785D0 (no)	2003-08-26
PL365746A1 (en)	2005-01-10
DE60206889T2 (de)	2006-07-27
WO2002067893A3 (en)	2003-01-16
CZ20032225A3 (cs)	2003-11-12
CN1503662A (zh)	2004-06-09
US20040067257A1 (en)	2004-04-08
RU2003128971A (ru)	2005-03-10
NZ527532A (en)	2004-12-24
HUP0302847A2 (hu)	2003-12-29
EP1368001B1 (en)	2005-10-26
JP2004143185A (ja)	2004-05-20
KR20030077042A (ko)	2003-09-29
WO2002067893A2 (en)	2002-09-06
AR032912A1 (es)	2003-12-03
JP3548566B2 (ja)	2004-07-28
ATE307571T1 (de)	2005-11-15

Publication	Publication Date	Title
IS6915A (is)	2003-08-15	Lyfjablanda
FI20010780A0 (fi)	2001-04-12	Parannetut koostumukset
DK1671949T3 (da)	2008-11-03	Substituerede pyridinylaminer
DE50204184D1 (de)	2005-10-13	Espressobrüheinrichtung
ATE524462T1 (de)	2011-09-15	C5-modifizierte indazolylpyrrolotriazine
BR0210619A (pt)	2006-05-23	composição
DE50204386D1 (de)	2006-02-09	Kreuztransducer
IS7081A (is)	2003-12-16	Lyfjablanda
DE50206892D1 (de)	2006-06-29	Substituierte imidazotriazinone
ATE335486T1 (de)	2006-09-15	Hydrazono-malonitrile
DK1373228T3 (da)	2008-08-04	Substituerede fluoralkoxyphenylsulfonylurinstoffer
DE50203412D1 (de)	2005-07-21	Schwenkkolbenverdränger
DE50203984D1 (de)	2005-09-22	Kugelgelenk
DE60214433D1 (de)	2006-10-12	Zughakensystem
ATE355059T1 (de)	2006-03-15	Isoxazolopyridinone
DE50213651D1 (de)	2009-08-13	Substituierte 4-aminocyclohexanole
DE50201862D1 (de)	2005-01-27	Messwandler
DE50203093D1 (de)	2005-06-16	Losradlager
ATA18372001A (de)	2005-07-15	Gelenksbolzenbaueinheit
ATE319694T1 (de)	2006-03-15	Phenylalkyne
ITTO20020747A0 (it)	2002-08-23	Composizione
DE50202088D1 (de)	2005-03-03	Garmodulsystem
ATA13992002A (de)	2003-10-15	Schlackengranulierungsanlage
ITTO20020745A0 (it)	2002-08-23	Composizione
DE10295006D2 (de)	2004-10-07	Bauwerksabdichtung